Replimune Group Inc. (REPL) NASDAQ
$6.97 (0.24) (-3.33%)
Market Cap: $442.61M
As of 04/18/24 04:00 PM EDT. Market closed.
Replimune Group Inc. (REPL)
NASDAQ
$6.97
(0.24) (-3.33%)
Market Cap: $442.61M
As of 04/18/24 04:00 PM EDT. Market closed.
Add to Portfolio
replimune group, inc., a biotechnology company, develops oncolytic immune-gene therapies to treat cancer. it uses its proprietary immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. the company's lead product candidate is rp1, a selectively replicating version of herpes simplex virus 1, which is in phase i/ii clinical trials ... read more
replimune group, inc., a biotechnology company, develops oncolytic immune-gene therapies to treat cancer. it uses its proprietary immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. the company's lead product candidate is rp1, a selectively replicating version of herpes simplex virus 1, which is in phase i/ii clinical trials for a range of solid tumors; and that is in phase ii clinical trials for patients with cutaneous squamous cell carcinoma. it is also developing rp2, which is in phase i clinical trials for an anti-ctla-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by ctla-4; and rp3 to express immune-activating proteins that stimulate t cells. replimune group, inc. was founded in 2015 and is headquartered in woburn, massachusetts. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Robert Coffin
Full Time Employees
244
CEO Compensation (Base)
$477,991
CEO Compensation (Total)
$2.27M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Robert Coffin
Full Time Employees
244
CEO Compensation (Base)
$477,991
CEO Compensation (Total)
$2.27M
Address
500 Unicorn Park Dr, Massachusetts, Woburn, 01801-3377.
PRICE CHART FOR REPLIMUNE GROUP INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$7.27
Previous Close
$7.21
Days Range
$7.14 - $7.33
52 week range
$5.89 - $24.81
Volume
1,126,229
Avg. Volume (30 days)
851,455
Market Cap
$442.61M
Dividend Yield
-
P/E
-
Shares Outstanding
61,387,786
Open
$7.27
Previous Close
$7.21
Days Range
$7.14 - $7.33
52 week range
$5.89 - $24.81
Volume
1,126,229
Avg. Volume (30 days)
851,455
Market Cap
$442.61M
Dividend Yield
-
P/E
-
Shares Outstanding
61,387,786
FINANCIAL STATEMENTS FOR REPLIMUNE GROUP INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR REPLIMUNE GROUP INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Xynos Konstantinos | Chief Medical Officer | Nov 16, 2023 | Sale | $10.92 | 7,313 | 79,858 | 112,714 | Nov 17, 2023, 08:01 PM |
| Sarchi Christopher | Chief Commercial Officer | Nov 16, 2023 | Sale | $10.92 | 5,255 | 57,385 | 72,245 | Nov 17, 2023, 08:00 PM |
| Esposito Pamela | Chief Business Officer | Sep 12, 2023 | Option Exercise | $3.30 | 300 | 990 | 263,736 | Sep 13, 2023, 09:02 PM |
| Esposito Pamela | Chief Business Officer | Sep 11, 2023 | Option Exercise | $3.30 | 5,358 | 17,681 | 268,794 | Sep 13, 2023, 09:02 PM |
| Esposito Pamela | Chief Business Officer | Sep 12, 2023 | Sale | $20.00 | 300 | 6,000 | 263,436 | Sep 13, 2023, 09:02 PM |
| Esposito Pamela | Chief Business Officer | Sep 11, 2023 | Sale | $20.01 | 5,358 | 107,214 | 263,436 | Sep 13, 2023, 09:02 PM |
| Esposito Pamela | Chief Business Officer | Aug 22, 2023 | Option Exercise | $6.58 | 18,600 | 122,380 | 282,036 | Aug 24, 2023, 08:30 PM |
| Esposito Pamela | Chief Business Officer | Aug 22, 2023 | Sale | $20.01 | 18,600 | 372,186 | 263,436 | Aug 24, 2023, 08:30 PM |
| Esposito Pamela | Chief Business Officer | Aug 11, 2023 | Option Exercise | $3.30 | 1,400 | 4,620 | 264,836 | Aug 15, 2023, 08:30 PM |
| Esposito Pamela | Chief Business Officer | Aug 11, 2023 | Sale | $20.00 | 1,400 | 28,000 | 263,436 | Aug 15, 2023, 08:30 PM |
| Esposito Pamela | Chief Business Officer | Jul 10, 2023 | Option Exercise | $6.35 | 20,000 | 127,000 | 283,436 | Jul 11, 2023, 09:00 PM |
| Esposito Pamela | Chief Business Officer | Jul 10, 2023 | Sale | $21.58 | 20,000 | 431,541 | 265,513 | Jul 11, 2023, 09:00 PM |
| Lewis Tanya | Chief Dev. Op. Officer | Jun 13, 2023 | Sale | $24.06 | 12,860 | 309,395 | 136,110 | Jun 15, 2023, 09:01 PM |
| Patel Sushil | Chief Strategy Officer | Jun 13, 2023 | Sale | $24.04 | 5,698 | 137,008 | 149,426 | Jun 15, 2023, 09:00 PM |
| Patel Sushil | Chief Strategy Officer | May 16, 2023 | Sale | $18.05 | 15,575 | 281,129 | 154,571 | May 18, 2023, 08:36 PM |
| Coffin Robert | President & Chief R&D Officer | May 16, 2023 | Sale | $18.05 | 7,861 | 141,891 | 1,833,336 | May 18, 2023, 08:35 PM |
| Lewis Tanya | Chief Dev. Op. Officer | May 16, 2023 | Sale | $18.05 | 12,207 | 220,336 | 148,153 | May 18, 2023, 08:34 PM |
| Love Colin | Chief Operating Officer | May 16, 2023 | Sale | $18.05 | 10,775 | 194,489 | 794,960 | May 18, 2023, 08:33 PM |
| Franchi Jean M. | Chief Financial Officer | May 16, 2023 | Sale | $18.05 | 11,351 | 204,886 | 128,748 | May 18, 2023, 08:32 PM |
| Xynos Konstantinos | Chief Medical Officer | May 16, 2023 | Sale | $18.05 | 771 | 13,917 | 120,027 | May 18, 2023, 08:31 PM |
| Esposito Pamela | Chief Business Officer | May 16, 2023 | Sale | $18.05 | 5,966 | 107,686 | 263,436 | May 18, 2023, 08:31 PM |
| Astley-Sparke Philip | Chief Executive Officer | May 16, 2023 | Sale | $18.05 | 17,902 | 323,131 | 1,525,278 | May 18, 2023, 08:30 PM |
| Esposito Pamela | Chief Business Officer | Dec 09, 2022 | Option Exercise | $1.01 | 15,000 | 15,150 | 244,402 | Dec 13, 2022, 08:01 PM |
| Esposito Pamela | Chief Business Officer | Dec 09, 2022 | Sale | $25.03 | 15,000 | 375,450 | 229,402 | Dec 13, 2022, 08:01 PM |
| Love Colin | Chief Operating Officer | May 16, 2022 | Sale | $14.59 | 6,324 | 92,267 | 765,735 | May 18, 2022, 07:04 PM |
| Esposito Pamela | Chief Business Officer | May 16, 2022 | Sale | $14.59 | 3,507 | 51,167 | 229,402 | May 18, 2022, 07:03 PM |
| Franchi Jean M. | Chief Financial Officer | May 16, 2022 | Sale | $14.59 | 3,436 | 50,131 | 95,099 | May 18, 2022, 07:03 PM |
| Lewis Tanya | Chief Dev. Op Officer | May 16, 2022 | Sale | $14.59 | 5,473 | 79,851 | 120,360 | May 18, 2022, 07:02 PM |
| Patel Sushil | Chief Commercial Officer | May 16, 2022 | Sale | $14.59 | 10,687 | 155,923 | 130,146 | May 18, 2022, 07:01 PM |
| Coffin Robert | President & Chief R&D Officer | May 16, 2022 | Sale | $14.59 | 5,737 | 83,703 | 1,796,197 | May 18, 2022, 07:01 PM |
| Astley-Sparke Philip | Chief Executive Officer | May 16, 2022 | Sale | $14.59 | 9,632 | 140,531 | 1,401,080 | May 18, 2022, 07:00 PM |
| Omega Fund IV, L.P. | 10% Owner | Mar 14, 2022 | Option Exercise | $9.78 | 16,500 | 161,370 | 4,779,880 | Mar 16, 2022, 09:54 PM |
| Omega Fund IV, L.P. | 10% Owner | Mar 14, 2022 | Sale | $15.42 | 16,500 | 254,430 | 4,763,380 | Mar 16, 2022, 09:54 PM |
| Omega Fund IV, L.P. | 10% Owner | Mar 16, 2022 | Sale | $15.52 | 45,000 | 698,253 | 4,712,142 | Mar 16, 2022, 09:54 PM |
| Omega Fund IV, L.P. | 10% Owner | Mar 15, 2022 | Sale | $15.64 | 45,000 | 703,800 | 4,718,380 | Mar 16, 2022, 09:54 PM |
| Omega Fund IV, L.P. | Director | Nov 22, 2021 | Sale | $34.70 | 10,162 | 352,621 | 4,763,380 | Nov 23, 2021, 04:53 PM |
| Omega Fund IV, L.P. | Director | Nov 19, 2021 | Sale | $34.54 | 35,262 | 1,218,058 | 4,773,959 | Nov 23, 2021, 04:53 PM |
| Omega Fund IV, L.P. | Director | Nov 18, 2021 | Sale | $33.50 | 2,441 | 81,774 | 4,808,804 | Nov 18, 2021, 06:30 PM |
| Omega Fund IV, L.P. | Director | Nov 16, 2021 | Sale | $33.50 | 153 | 5,126 | 4,811,245 | Nov 18, 2021, 06:30 PM |
| Omega Fund IV, L.P. | Director | Nov 16, 2021 | Sale | $33.50 | 153 | 5,126 | 4,811,245 | Nov 18, 2021, 06:30 PM |
| Omega Fund IV, L.P. | Director | Nov 18, 2021 | Sale | $33.50 | 2,441 | 81,774 | 4,808,804 | Nov 18, 2021, 06:30 PM |
| Omega Fund IV, L.P. | Director | Nov 15, 2021 | Sale | $33.66 | 782 | 26,322 | 4,811,398 | Nov 16, 2021, 01:29 PM |
| Omega Fund IV, L.P. | Director | Nov 12, 2021 | Sale | $33.66 | 23,235 | 782,090 | 4,812,180 | Nov 16, 2021, 01:29 PM |
| Omega Fund IV, L.P. | Director | Nov 11, 2021 | Sale | $33.61 | 18,279 | 614,357 | 4,835,415 | Nov 12, 2021, 01:08 PM |
| Omega Fund IV, L.P. | Director | Nov 10, 2021 | Sale | $33.50 | 11 | 369 | 4,853,694 | Nov 12, 2021, 01:08 PM |
| Omega Fund IV, L.P. | Director | Nov 08, 2021 | Sale | $33.53 | 3,817 | 127,984 | 4,861,242 | Nov 10, 2021, 12:16 PM |
| Omega Fund IV, L.P. | Director | Nov 09, 2021 | Sale | $33.73 | 7,537 | 254,223 | 4,853,705 | Nov 10, 2021, 12:16 PM |
| Omega Fund IV, L.P. | Director | Nov 05, 2021 | Sale | $33.50 | 5,790 | 193,965 | 4,865,059 | Nov 08, 2021, 02:14 PM |
| Omega Fund IV, L.P. | Director | Nov 04, 2021 | Sale | $33.58 | 25,225 | 847,056 | 4,870,849 | Nov 08, 2021, 02:14 PM |
| Love Colin | Chief Operating Officer | Oct 18, 2021 | Sale | $29.58 | 12,711 | 375,991 | 745,809 | Oct 19, 2021, 09:01 PM |
| Love Colin | Chief Operating Officer | Oct 15, 2021 | Sale | $30.42 | 17,289 | 525,900 | 773,609 | Oct 19, 2021, 09:01 PM |
| Omega Fund IV, L.P. | Director | Sep 23, 2021 | Sale | $33.58 | 12,171 | 408,702 | 4,896,074 | Sep 27, 2021, 08:50 PM |
| Omega Fund IV, L.P. | Director | Sep 17, 2021 | Sale | $33.02 | 94,463 | 3,118,779 | 4,923,710 | Sep 20, 2021, 12:53 PM |
| Omega Fund IV, L.P. | Director | Sep 16, 2021 | Sale | $32.55 | 5,537 | 180,229 | 5,002,708 | Sep 20, 2021, 12:53 PM |
| Love Colin | Chief Operating Officer | Sep 15, 2021 | Sale | $31.23 | 30,000 | 936,900 | 775,809 | Sep 17, 2021, 09:11 PM |
| Love Colin | Chief Operating Officer | Aug 16, 2021 | Sale | $29.93 | 30,000 | 898,029 | 808,509 | Aug 18, 2021, 09:00 PM |
| Esposito Pamela | Chief Business Officer | Aug 04, 2021 | Option Exercise | $15.50 | 4,200 | 65,100 | 214,359 | Aug 06, 2021, 09:01 PM |
| Esposito Pamela | Chief Business Officer | Aug 05, 2021 | Option Exercise | $15.50 | 25,800 | 399,900 | 235,959 | Aug 06, 2021, 09:01 PM |
| Esposito Pamela | Chief Business Officer | Aug 05, 2021 | Sale | $35.09 | 25,800 | 905,322 | 210,159 | Aug 06, 2021, 09:01 PM |
| Esposito Pamela | Chief Business Officer | Aug 04, 2021 | Sale | $35.00 | 4,200 | 147,000 | 210,159 | Aug 06, 2021, 09:01 PM |
| Esposito Pamela | Chief Business Officer | Jul 21, 2021 | Option Exercise | $1.01 | 12,538 | 12,663 | 222,697 | Jul 22, 2021, 09:01 PM |
| Esposito Pamela | Chief Business Officer | Jul 20, 2021 | Option Exercise | $1.01 | 4,862 | 4,911 | 215,021 | Jul 22, 2021, 09:01 PM |
| Esposito Pamela | Chief Business Officer | Jul 21, 2021 | Sale | $33.17 | 12,538 | 415,885 | 210,159 | Jul 22, 2021, 09:01 PM |
| Esposito Pamela | Chief Business Officer | Jul 20, 2021 | Sale | $33.05 | 4,862 | 160,689 | 210,159 | Jul 22, 2021, 09:01 PM |
| Esposito Pamela | Chief Business Officer | Jul 15, 2021 | Option Exercise | $1.01 | 4,600 | 4,646 | 214,759 | Jul 19, 2021, 09:02 PM |
| Esposito Pamela | Chief Business Officer | Jul 15, 2021 | Sale | $33.37 | 4,600 | 153,502 | 210,159 | Jul 19, 2021, 09:02 PM |
| Esposito Pamela | Chief Business Officer | Jan 19, 2021 | Option Exercise | $1.01 | 5,727 | 5,784 | 181,721 | Jul 19, 2021, 09:02 PM |
| Esposito Pamela | Chief Business Officer | Jan 15, 2021 | Option Exercise | $1.01 | 29,273 | 29,566 | 205,267 | Jul 19, 2021, 09:02 PM |
| Esposito Pamela | Chief Business Officer | Jan 14, 2021 | Option Exercise | $1.01 | 20,000 | 20,200 | 195,994 | Jul 19, 2021, 09:02 PM |
| Esposito Pamela | Chief Business Officer | Jan 19, 2021 | Sale | $42.47 | 5,727 | 243,226 | 181,121 | Jul 19, 2021, 09:02 PM |
| Esposito Pamela | Chief Business Officer | Jan 15, 2021 | Sale | $43.58 | 29,273 | 1,275,717 | 175,994 | Jul 19, 2021, 09:02 PM |
| Esposito Pamela | Chief Business Officer | Jan 14, 2021 | Sale | $45.02 | 20,000 | 900,400 | 175,994 | Jul 19, 2021, 09:02 PM |
| Love Colin | Chief Operating Officer | Jul 15, 2021 | Sale | $32.02 | 30,000 | 960,600 | 835,809 | Jul 16, 2021, 09:03 PM |
| Coffin Robert | President & Chief R&D Officer | Jul 02, 2021 | Sale | $40.04 | 7,810 | 312,712 | 1,775,684 | Jul 07, 2021, 09:01 PM |
| Coffin Robert | President & Chief R&D Officer | Jun 29, 2021 | Sale | $40.05 | 22,826 | 914,181 | 1,783,494 | Jun 30, 2021, 09:00 PM |
| Coffin Robert | President & Chief R&D Officer | Jun 28, 2021 | Sale | $40.04 | 14,663 | 587,107 | 1,806,320 | Jun 30, 2021, 09:00 PM |
| Love Colin | Chief Operating Officer | Jun 15, 2021 | Sale | $34.10 | 30,000 | 1,022,906 | 878,009 | Jun 16, 2021, 09:47 PM |
| Love Colin | Chief Operating Officer | Apr 15, 2021 | Sale | $30.63 | 30,000 | 918,783 | 898,509 | Apr 19, 2021, 06:35 PM |
| Love Colin | Chief Operating Officer | Mar 15, 2021 | Sale | $33.54 | 30,000 | 1,006,106 | 905,142 | Mar 17, 2021, 09:07 PM |
| Love Colin | Chief Operating Officer | Feb 16, 2021 | Sale | $36.32 | 30,000 | 1,089,537 | 927,904 | Feb 18, 2021, 05:58 PM |
| Omega Fund IV, L.P. | 10% Owner | Feb 08, 2021 | Sale | $45.00 | 5,249 | 236,205 | 5,141,321 | Feb 11, 2021, 11:50 AM |
| Rhodes Jason P | Director | Jan 26, 2021 | Sale | $46.14 | 5,558 | 256,446 | 946,000 | Jan 28, 2021, 05:08 PM |
| Omega Fund IV, L.P. | Director | Jan 26, 2021 | Sale | $45.42 | 30,350 | 1,378,444 | 5,287,075 | Jan 28, 2021, 09:27 AM |
| Coffin Robert | President & Chief R&D Officer | Jan 22, 2021 | Sale | $44.43 | 60,000 | 2,665,973 | 1,773,921 | Jan 26, 2021, 09:00 PM |
| Omega Fund IV, L.P. | Director | Jan 22, 2021 | Sale | $45.04 | 11,359 | 511,658 | 5,317,301 | Jan 26, 2021, 09:56 AM |
| Astley-Sparke Philip | Chief Executive Officer | Jan 19, 2021 | Sale | $42.47 | 8,432 | 358,117 | 1,262,929 | Jan 19, 2021, 09:53 PM |
| Astley-Sparke Philip | Chief Executive Officer | Jan 15, 2021 | Sale | $43.40 | 16,568 | 719,059 | 1,279,197 | Jan 19, 2021, 09:53 PM |
| Astley-Sparke Philip | Chief Executive Officer | Jan 14, 2021 | Sale | $44.42 | 25,000 | 1,110,614 | 1,287,845 | Jan 19, 2021, 09:53 PM |
| Esposito Pamela | Chief Business Officer | Jan 15, 2021 | Option Exercise | $1.01 | 29,273 | 29,566 | 205,267 | Jan 19, 2021, 09:50 PM |
| Esposito Pamela | Chief Business Officer | Jan 14, 2021 | Option Exercise | $1.01 | 20,000 | 20,200 | 195,994 | Jan 19, 2021, 09:50 PM |
| Esposito Pamela | Chief Business Officer | Jan 19, 2021 | Option Exercise | $1.01 | 5,727 | 5,784 | 181,721 | Jan 19, 2021, 09:50 PM |
| Esposito Pamela | Chief Business Officer | Jan 14, 2021 | Sale | $45.02 | 20,000 | 900,400 | 175,994 | Jan 19, 2021, 09:50 PM |
| Esposito Pamela | Chief Business Officer | Jan 19, 2021 | Sale | $42.47 | 5,727 | 243,226 | 181,121 | Jan 19, 2021, 09:50 PM |
| Esposito Pamela | Chief Business Officer | Jan 15, 2021 | Sale | $43.58 | 29,273 | 1,275,717 | 175,994 | Jan 19, 2021, 09:50 PM |
| Love Colin | Chief Operating Officer | Jan 19, 2021 | Sale | $42.46 | 7,857 | 333,589 | 953,681 | Jan 19, 2021, 09:47 PM |
| Love Colin | Chief Operating Officer | Jan 15, 2021 | Sale | $43.51 | 22,143 | 963,476 | 974,324 | Jan 19, 2021, 09:47 PM |
| Omega Fund IV, L.P. | Director | Jan 15, 2021 | Sale | $45.19 | 1,916 | 86,584 | 5,325,391 | Jan 19, 2021, 03:02 PM |
| Omega Fund IV, L.P. | Director | Jan 14, 2021 | Sale | $45.09 | 17,664 | 796,470 | 5,327,307 | Jan 19, 2021, 03:02 PM |
| Franchi Jean M. | Chief Financial Officer | Jan 14, 2021 | Option Exercise | $14.08 | 14,900 | 209,792 | 14,900 | Jan 15, 2021, 09:01 PM |
| Franchi Jean M. | Chief Financial Officer | Jan 13, 2021 | Option Exercise | $14.08 | 100 | 1,408 | 100 | Jan 15, 2021, 09:01 PM |
| Franchi Jean M. | Chief Financial Officer | Jan 14, 2021 | Sale | $44.53 | 14,900 | 663,465 | 600 | Jan 15, 2021, 09:01 PM |
| Franchi Jean M. | Chief Financial Officer | Jan 13, 2021 | Sale | $44.19 | 100 | 4,419 | 0 | Jan 15, 2021, 09:01 PM |
| Coffin Robert | President & Chief R&D Officer | Dec 22, 2020 | Sale | $40.04 | 220,000 | 8,808,800 | 1,804,118 | Dec 28, 2020, 09:03 PM |
| Esposito Pamela | Chief Business Officer | Dec 23, 2020 | Option Exercise | $1.75 | 50,704 | 88,732 | 175,994 | Dec 28, 2020, 09:01 PM |
| Rhodes Jason P | Director | Dec 18, 2020 | Sale | $41.95 | 4,319 | 181,182 | 2,263,627 | Dec 22, 2020, 04:38 PM |
| Rhodes Jason P | Director | Dec 17, 2020 | Sale | $42.00 | 11,535 | 484,470 | 2,266,639 | Dec 17, 2020, 06:21 PM |
| Rhodes Jason P | Director | Dec 16, 2020 | Sale | $42.13 | 12,675 | 533,998 | 2,274,692 | Dec 17, 2020, 06:21 PM |
| Rhodes Jason P | Director | Dec 15, 2020 | Sale | $42.41 | 40,819 | 1,731,253 | 2,283,960 | Dec 17, 2020, 06:21 PM |
| Franchi Jean M. | Chief Financial Officer | Dec 14, 2020 | Option Exercise | $14.08 | 25,000 | 352,000 | 25,000 | Dec 16, 2020, 09:00 PM |
| Franchi Jean M. | Chief Financial Officer | Dec 14, 2020 | Sale | $43.45 | 25,000 | 1,086,200 | 7,144 | Dec 16, 2020, 09:00 PM |
| Esposito Pamela | Chief Business Officer | Dec 11, 2020 | Option Exercise | $3.30 | 12,590 | 41,547 | 125,290 | Dec 15, 2020, 09:35 PM |
| Rhodes Jason P | Director | Dec 14, 2020 | Sale | $43.49 | 37,659 | 1,637,847 | 2,335,553 | Dec 14, 2020, 07:20 PM |
| Rhodes Jason P | Director | Dec 11, 2020 | Sale | $43.38 | 31,636 | 1,372,512 | 2,340,703 | Dec 14, 2020, 07:20 PM |
| Rhodes Jason P | Director | Dec 10, 2020 | Sale | $43.15 | 34,391 | 1,484,083 | 2,371,734 | Dec 14, 2020, 07:20 PM |
| Astley-Sparke Philip | Chief Executive Officer | Dec 10, 2020 | Sale | $43.05 | 25,000 | 1,076,145 | 1,325,211 | Dec 11, 2020, 09:00 PM |
| Astley-Sparke Philip | Chief Executive Officer | Dec 09, 2020 | Sale | $43.75 | 25,000 | 1,093,729 | 1,354,697 | Dec 11, 2020, 09:00 PM |
| Love Colin | Chief Operating Officer | Dec 09, 2020 | Sale | $43.75 | 30,000 | 1,312,382 | 1,005,824 | Dec 11, 2020, 09:00 PM |
| Rhodes Jason P | Director | Dec 09, 2020 | Sale | $43.77 | 41,216 | 1,804,182 | 2,411,385 | Dec 09, 2020, 07:54 PM |
| Rhodes Jason P | Director | Dec 08, 2020 | Sale | $46.71 | 108,256 | 5,056,591 | 2,446,263 | Dec 09, 2020, 07:54 PM |
| Rhodes Jason P | Director | Dec 07, 2020 | Sale | $45.96 | 67,890 | 3,120,459 | 2,477,660 | Dec 09, 2020, 07:54 PM |
| SLATTERY JOSEPH P | Director | Dec 08, 2020 | Option Exercise | $3.30 | 5,200 | 17,160 | 11,867 | Dec 09, 2020, 07:50 PM |
| SLATTERY JOSEPH P | Director | Dec 08, 2020 | Sale | $46.00 | 5,200 | 239,200 | 6,667 | Dec 09, 2020, 07:50 PM |
| Dhingra Kapil | Director | Dec 07, 2020 | Option Exercise | $1.75 | 40,000 | 70,000 | 40,000 | Dec 09, 2020, 07:48 PM |
| Dhingra Kapil | Director | Dec 07, 2020 | Sale | $45.56 | 40,000 | 1,822,395 | 15,325 | Dec 09, 2020, 07:48 PM |
| Love Colin | Chief Operating Officer | Nov 16, 2020 | Sale | $44.91 | 15,000 | 673,649 | 1,021,224 | Nov 18, 2020, 08:00 PM |
| Esposito Pamela | Chief Business Officer | Oct 14, 2020 | Option Exercise | $1.01 | 16,000 | 16,160 | 128,700 | Oct 16, 2020, 06:05 PM |
| Esposito Pamela | Chief Business Officer | Oct 14, 2020 | Sale | $32.90 | 16,000 | 526,410 | 121,700 | Oct 16, 2020, 06:05 PM |
| Love Colin | Chief Operating Officer | Sep 15, 2020 | Sale | $23.97 | 15,000 | 359,487 | 1,033,324 | Sep 17, 2020, 04:25 PM |
| Esposito Pamela | Chief Business Officer | Aug 31, 2020 | Option Exercise | $1.01 | 5,000 | 5,050 | 117,700 | Sep 01, 2020, 05:13 PM |
| Esposito Pamela | Chief Business Officer | Aug 31, 2020 | Sale | $27.05 | 5,000 | 135,250 | 112,700 | Sep 01, 2020, 05:13 PM |
| Love Colin | Chief Operating Officer | Aug 17, 2020 | Sale | $23.44 | 15,000 | 351,555 | 1,042,488 | Aug 18, 2020, 05:15 PM |
| Coffin Robert | President & Chief R&D Officer | Jul 09, 2020 | Sale | $22.13 | 169,750 | 3,757,295 | 2,048,368 | Jul 10, 2020, 09:00 PM |
| Coffin Robert | Pres & Chief Res & Dev Officer | Feb 20, 2020 | Sale | $17.04 | 24,250 | 413,220 | 2,193,868 | Feb 24, 2020, 04:02 PM |
| Coffin Robert | Pres & Chief Res & Dev Officer | Feb 12, 2020 | Sale | $17.04 | 48,500 | 826,198 | 2,242,368 | Feb 14, 2020, 04:00 PM |
| Esposito Pamela | Chief Business Officer | Dec 20, 2019 | Option Exercise | $1.75 | 25,700 | 44,975 | 112,700 | Dec 23, 2019, 04:32 PM |
| Kaufman Howard | Chief Medical Officer | Nov 26, 2019 | Option Exercise | $3.30 | 58,067 | 191,621 | 58,067 | Dec 19, 2019, 04:02 PM |
| Rhodes Jason P | Director | Nov 18, 2019 | Buy | $13.61 | 1,100,000 | 14,971,000 | 1,100,000 | Nov 20, 2019, 05:50 PM |
| Omega Fund IV, L.P. | 10% Owner | Nov 18, 2019 | Buy | $13.61 | 220,000 | 2,994,200 | 5,328,939 | Nov 20, 2019, 12:36 PM |
| Love Colin | Chief Operating Officer | Nov 06, 2019 | Sale | $17.01 | 22,500 | 382,725 | 1,062,774 | Nov 08, 2019, 09:16 PM |
| Astley-Sparke Philip | Executive Chairman | Nov 06, 2019 | Sale | $17.01 | 29,000 | 493,290 | 1,369,797 | Nov 08, 2019, 09:16 PM |
| Coffin Robert | President and CEO | Nov 06, 2019 | Sale | $17.01 | 48,500 | 824,985 | 2,290,868 | Nov 08, 2019, 09:15 PM |
| Astley-Sparke Philip | Executive Chairman | Nov 04, 2019 | Sale | $17.03 | 29,000 | 493,754 | 1,398,797 | Nov 06, 2019, 07:38 PM |
| Love Colin | Chief Operating Officer | Nov 04, 2019 | Sale | $17.03 | 22,500 | 383,085 | 1,085,274 | Nov 06, 2019, 07:37 PM |
| Coffin Robert | President and CEO | Nov 04, 2019 | Sale | $17.03 | 48,500 | 825,761 | 2,339,368 | Nov 06, 2019, 07:37 PM |
| Coffin Robert | President and CEO | Oct 31, 2019 | Sale | $17.00 | 24,250 | 412,250 | 2,363,618 | Nov 04, 2019, 04:17 PM |
| Astley-Sparke Philip | Executive Chairman | Oct 31, 2019 | Sale | $17.00 | 14,500 | 246,500 | 1,413,297 | Nov 04, 2019, 04:16 PM |
| Love Colin | Chief Operating Officer | Oct 31, 2019 | Sale | $17.00 | 11,250 | 191,250 | 1,096,524 | Nov 04, 2019, 04:15 PM |
| Astley-Sparke Philip | Executive Chairman | Sep 23, 2019 | Sale | $17.05 | 14,500 | 247,225 | 1,427,797 | Sep 25, 2019, 04:31 PM |
| Love Colin | Chief Operating Officer | Sep 23, 2019 | Sale | $17.05 | 11,250 | 191,812 | 1,107,774 | Sep 25, 2019, 04:31 PM |
| Coffin Robert | President and CEO | Sep 23, 2019 | Sale | $17.05 | 24,250 | 413,462 | 2,387,868 | Sep 25, 2019, 04:30 PM |
| Esposito Pamela | Chief Business Officer | Dec 13, 2018 | Option Exercise | $1.75 | 87,000 | 152,250 | 87,000 | Dec 17, 2018, 04:16 PM |
| Slootweg Hugo Alexander | Director | Jul 24, 2018 | Buy | $15.00 | 133,333 | 1,999,995 | 4,721,449 | Jul 26, 2018, 05:26 PM |
| SLATTERY JOSEPH P | Director | Jul 24, 2018 | Buy | $15.00 | 6,667 | 100,005 | 6,667 | Jul 26, 2018, 05:16 PM |
| Forbion Capital Fund III Cooperatief U.A. | 10% Owner | Jul 24, 2018 | Buy | $15.00 | 133,333 | 1,999,995 | 4,721,449 | Jul 26, 2018, 05:16 PM |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | Jul 24, 2018 | Buy | $15.00 | 500,000 | 7,500,000 | 2,838,968 | Jul 26, 2018, 04:27 PM |
| Omega Fund IV, L.P. | 10% Owner | Jul 24, 2018 | Buy | $15.00 | 266,667 | 4,000,005 | 266,667 | Jul 25, 2018, 05:09 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Xynos Konstantinos | Chief Medical Officer | 11/16/2023 | 79,858 |
| Sarchi Christopher | Chief Commercial Officer | 11/16/2023 | 57,385 |
| Esposito Pamela | Chief Business Officer | 09/12/2023 | 990 |
| Esposito Pamela | Chief Business Officer | 09/11/2023 | 17,681 |
| Esposito Pamela | Chief Business Officer | 09/12/2023 | 6,000 |
| Esposito Pamela | Chief Business Officer | 09/11/2023 | 107,214 |
| Esposito Pamela | Chief Business Officer | 08/22/2023 | 122,380 |
| Esposito Pamela | Chief Business Officer | 08/22/2023 | 372,186 |
| Esposito Pamela | Chief Business Officer | 08/11/2023 | 4,620 |
| Esposito Pamela | Chief Business Officer | 08/11/2023 | 28,000 |
| Esposito Pamela | Chief Business Officer | 07/10/2023 | 127,000 |
| Esposito Pamela | Chief Business Officer | 07/10/2023 | 431,541 |
| Lewis Tanya | Chief Dev. Op. Officer | 06/13/2023 | 309,395 |
| Patel Sushil | Chief Strategy Officer | 06/13/2023 | 137,008 |
| Patel Sushil | Chief Strategy Officer | 05/16/2023 | 281,129 |
| Coffin Robert | President & Chief R&D Officer | 05/16/2023 | 141,891 |
| Lewis Tanya | Chief Dev. Op. Officer | 05/16/2023 | 220,336 |
| Love Colin | Chief Operating Officer | 05/16/2023 | 194,489 |
| Franchi Jean M. | Chief Financial Officer | 05/16/2023 | 204,886 |
| Xynos Konstantinos | Chief Medical Officer | 05/16/2023 | 13,917 |
| Esposito Pamela | Chief Business Officer | 05/16/2023 | 107,686 |
| Astley-Sparke Philip | Chief Executive Officer | 05/16/2023 | 323,131 |
| Esposito Pamela | Chief Business Officer | 12/09/2022 | 15,150 |
| Esposito Pamela | Chief Business Officer | 12/09/2022 | 375,450 |
| Love Colin | Chief Operating Officer | 05/16/2022 | 92,267 |
| Esposito Pamela | Chief Business Officer | 05/16/2022 | 51,167 |
| Franchi Jean M. | Chief Financial Officer | 05/16/2022 | 50,131 |
| Lewis Tanya | Chief Dev. Op Officer | 05/16/2022 | 79,851 |
| Patel Sushil | Chief Commercial Officer | 05/16/2022 | 155,923 |
| Coffin Robert | President & Chief R&D Officer | 05/16/2022 | 83,703 |
| Astley-Sparke Philip | Chief Executive Officer | 05/16/2022 | 140,531 |
| Omega Fund IV, L.P. | 10% Owner | 03/14/2022 | 161,370 |
| Omega Fund IV, L.P. | 10% Owner | 03/14/2022 | 254,430 |
| Omega Fund IV, L.P. | 10% Owner | 03/16/2022 | 698,253 |
| Omega Fund IV, L.P. | 10% Owner | 03/15/2022 | 703,800 |
| Omega Fund IV, L.P. | Director | 11/22/2021 | 352,621 |
| Omega Fund IV, L.P. | Director | 11/19/2021 | 1,218,058 |
| Omega Fund IV, L.P. | Director | 11/18/2021 | 81,774 |
| Omega Fund IV, L.P. | Director | 11/16/2021 | 5,126 |
| Omega Fund IV, L.P. | Director | 11/16/2021 | 5,126 |
| Omega Fund IV, L.P. | Director | 11/18/2021 | 81,774 |
| Omega Fund IV, L.P. | Director | 11/15/2021 | 26,322 |
| Omega Fund IV, L.P. | Director | 11/12/2021 | 782,090 |
| Omega Fund IV, L.P. | Director | 11/11/2021 | 614,357 |
| Omega Fund IV, L.P. | Director | 11/10/2021 | 369 |
| Omega Fund IV, L.P. | Director | 11/08/2021 | 127,984 |
| Omega Fund IV, L.P. | Director | 11/09/2021 | 254,223 |
| Omega Fund IV, L.P. | Director | 11/05/2021 | 193,965 |
| Omega Fund IV, L.P. | Director | 11/04/2021 | 847,056 |
| Love Colin | Chief Operating Officer | 10/18/2021 | 375,991 |
| Love Colin | Chief Operating Officer | 10/15/2021 | 525,900 |
| Omega Fund IV, L.P. | Director | 09/23/2021 | 408,702 |
| Omega Fund IV, L.P. | Director | 09/17/2021 | 3,118,779 |
| Omega Fund IV, L.P. | Director | 09/16/2021 | 180,229 |
| Love Colin | Chief Operating Officer | 09/15/2021 | 936,900 |
| Love Colin | Chief Operating Officer | 08/16/2021 | 898,029 |
| Esposito Pamela | Chief Business Officer | 08/04/2021 | 65,100 |
| Esposito Pamela | Chief Business Officer | 08/05/2021 | 399,900 |
| Esposito Pamela | Chief Business Officer | 08/05/2021 | 905,322 |
| Esposito Pamela | Chief Business Officer | 08/04/2021 | 147,000 |
| Esposito Pamela | Chief Business Officer | 07/21/2021 | 12,663 |
| Esposito Pamela | Chief Business Officer | 07/20/2021 | 4,911 |
| Esposito Pamela | Chief Business Officer | 07/21/2021 | 415,885 |
| Esposito Pamela | Chief Business Officer | 07/20/2021 | 160,689 |
| Esposito Pamela | Chief Business Officer | 07/15/2021 | 4,646 |
| Esposito Pamela | Chief Business Officer | 07/15/2021 | 153,502 |
| Esposito Pamela | Chief Business Officer | 01/19/2021 | 5,784 |
| Esposito Pamela | Chief Business Officer | 01/15/2021 | 29,566 |
| Esposito Pamela | Chief Business Officer | 01/14/2021 | 20,200 |
| Esposito Pamela | Chief Business Officer | 01/19/2021 | 243,226 |
| Esposito Pamela | Chief Business Officer | 01/15/2021 | 1,275,717 |
| Esposito Pamela | Chief Business Officer | 01/14/2021 | 900,400 |
| Love Colin | Chief Operating Officer | 07/15/2021 | 960,600 |
| Coffin Robert | President & Chief R&D Officer | 07/02/2021 | 312,712 |
| Coffin Robert | President & Chief R&D Officer | 06/29/2021 | 914,181 |
| Coffin Robert | President & Chief R&D Officer | 06/28/2021 | 587,107 |
| Love Colin | Chief Operating Officer | 06/15/2021 | 1,022,906 |
| Love Colin | Chief Operating Officer | 04/15/2021 | 918,783 |
| Love Colin | Chief Operating Officer | 03/15/2021 | 1,006,106 |
| Love Colin | Chief Operating Officer | 02/16/2021 | 1,089,537 |
| Omega Fund IV, L.P. | 10% Owner | 02/08/2021 | 236,205 |
| Rhodes Jason P | Director | 01/26/2021 | 256,446 |
| Omega Fund IV, L.P. | Director | 01/26/2021 | 1,378,444 |
| Coffin Robert | President & Chief R&D Officer | 01/22/2021 | 2,665,973 |
| Omega Fund IV, L.P. | Director | 01/22/2021 | 511,658 |
| Astley-Sparke Philip | Chief Executive Officer | 01/19/2021 | 358,117 |
| Astley-Sparke Philip | Chief Executive Officer | 01/15/2021 | 719,059 |
| Astley-Sparke Philip | Chief Executive Officer | 01/14/2021 | 1,110,614 |
| Esposito Pamela | Chief Business Officer | 01/15/2021 | 29,566 |
| Esposito Pamela | Chief Business Officer | 01/14/2021 | 20,200 |
| Esposito Pamela | Chief Business Officer | 01/19/2021 | 5,784 |
| Esposito Pamela | Chief Business Officer | 01/14/2021 | 900,400 |
| Esposito Pamela | Chief Business Officer | 01/19/2021 | 243,226 |
| Esposito Pamela | Chief Business Officer | 01/15/2021 | 1,275,717 |
| Love Colin | Chief Operating Officer | 01/19/2021 | 333,589 |
| Love Colin | Chief Operating Officer | 01/15/2021 | 963,476 |
| Omega Fund IV, L.P. | Director | 01/15/2021 | 86,584 |
| Omega Fund IV, L.P. | Director | 01/14/2021 | 796,470 |
| Franchi Jean M. | Chief Financial Officer | 01/14/2021 | 209,792 |
| Franchi Jean M. | Chief Financial Officer | 01/13/2021 | 1,408 |
| Franchi Jean M. | Chief Financial Officer | 01/14/2021 | 663,465 |
| Franchi Jean M. | Chief Financial Officer | 01/13/2021 | 4,419 |
| Coffin Robert | President & Chief R&D Officer | 12/22/2020 | 8,808,800 |
| Esposito Pamela | Chief Business Officer | 12/23/2020 | 88,732 |
| Rhodes Jason P | Director | 12/18/2020 | 181,182 |
| Rhodes Jason P | Director | 12/17/2020 | 484,470 |
| Rhodes Jason P | Director | 12/16/2020 | 533,998 |
| Rhodes Jason P | Director | 12/15/2020 | 1,731,253 |
| Franchi Jean M. | Chief Financial Officer | 12/14/2020 | 352,000 |
| Franchi Jean M. | Chief Financial Officer | 12/14/2020 | 1,086,200 |
| Esposito Pamela | Chief Business Officer | 12/11/2020 | 41,547 |
| Rhodes Jason P | Director | 12/14/2020 | 1,637,847 |
| Rhodes Jason P | Director | 12/11/2020 | 1,372,512 |
| Rhodes Jason P | Director | 12/10/2020 | 1,484,083 |
| Astley-Sparke Philip | Chief Executive Officer | 12/10/2020 | 1,076,145 |
| Astley-Sparke Philip | Chief Executive Officer | 12/09/2020 | 1,093,729 |
| Love Colin | Chief Operating Officer | 12/09/2020 | 1,312,382 |
| Rhodes Jason P | Director | 12/09/2020 | 1,804,182 |
| Rhodes Jason P | Director | 12/08/2020 | 5,056,591 |
| Rhodes Jason P | Director | 12/07/2020 | 3,120,459 |
| SLATTERY JOSEPH P | Director | 12/08/2020 | 17,160 |
| SLATTERY JOSEPH P | Director | 12/08/2020 | 239,200 |
| Dhingra Kapil | Director | 12/07/2020 | 70,000 |
| Dhingra Kapil | Director | 12/07/2020 | 1,822,395 |
| Love Colin | Chief Operating Officer | 11/16/2020 | 673,649 |
| Esposito Pamela | Chief Business Officer | 10/14/2020 | 16,160 |
| Esposito Pamela | Chief Business Officer | 10/14/2020 | 526,410 |
| Love Colin | Chief Operating Officer | 09/15/2020 | 359,487 |
| Esposito Pamela | Chief Business Officer | 08/31/2020 | 5,050 |
| Esposito Pamela | Chief Business Officer | 08/31/2020 | 135,250 |
| Love Colin | Chief Operating Officer | 08/17/2020 | 351,555 |
| Coffin Robert | President & Chief R&D Officer | 07/09/2020 | 3,757,295 |
| Coffin Robert | Pres & Chief Res & Dev Officer | 02/20/2020 | 413,220 |
| Coffin Robert | Pres & Chief Res & Dev Officer | 02/12/2020 | 826,198 |
| Esposito Pamela | Chief Business Officer | 12/20/2019 | 44,975 |
| Kaufman Howard | Chief Medical Officer | 11/26/2019 | 191,621 |
| Rhodes Jason P | Director | 11/18/2019 | 14,971,000 |
| Omega Fund IV, L.P. | 10% Owner | 11/18/2019 | 2,994,200 |
| Love Colin | Chief Operating Officer | 11/06/2019 | 382,725 |
| Astley-Sparke Philip | Executive Chairman | 11/06/2019 | 493,290 |
| Coffin Robert | President and CEO | 11/06/2019 | 824,985 |
| Astley-Sparke Philip | Executive Chairman | 11/04/2019 | 493,754 |
| Love Colin | Chief Operating Officer | 11/04/2019 | 383,085 |
| Coffin Robert | President and CEO | 11/04/2019 | 825,761 |
| Coffin Robert | President and CEO | 10/31/2019 | 412,250 |
| Astley-Sparke Philip | Executive Chairman | 10/31/2019 | 246,500 |
| Love Colin | Chief Operating Officer | 10/31/2019 | 191,250 |
| Astley-Sparke Philip | Executive Chairman | 09/23/2019 | 247,225 |
| Love Colin | Chief Operating Officer | 09/23/2019 | 191,812 |
| Coffin Robert | President and CEO | 09/23/2019 | 413,462 |
| Esposito Pamela | Chief Business Officer | 12/13/2018 | 152,250 |
| Slootweg Hugo Alexander | Director | 07/24/2018 | 1,999,995 |
| SLATTERY JOSEPH P | Director | 07/24/2018 | 100,005 |
| Forbion Capital Fund III Cooperatief U.A. | 10% Owner | 07/24/2018 | 1,999,995 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | 07/24/2018 | 7,500,000 |
| Omega Fund IV, L.P. | 10% Owner | 07/24/2018 | 4,000,005 |
Load More Insider Transactions
FUNDS WITH A POSITION IN REPLIMUNE GROUP INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 9,545,336 | 0.92% | 108.49% | Other |
| BLACKROCK INC. | 4,538,487 | 0.00098% | 14.67% | Other |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,811,710 | 0.28% | New | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,145,112 | 0.00101% | 13.56% | Other |
| D. E. SHAW & CO., INC. | 243,006 | 0.00179% | 201.11% | Other |
| UBS OCONNOR LLC | 100,000 | 0.06% | New | Value |
| FISHER ASSET MANAGEMENT, LLC | 77,663 | 0.00035% | 37.71% | Other |
| ALPS ADVISORS INC | 39,774 | 0.00264% | -8.67% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 33,853 | 0.00044% | -60.95% | Other |
| AQR CAPITAL MANAGEMENT LLC | 17,825 | 0.00028% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR REPLIMUNE GROUP INC
STOCK BUYBACKS FOR REPLIMUNE GROUP INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.10%
1Q
06/30/2023
0.42%
2Q
03/31/2023
0.98%
3Q
12/31/2022
15.19%
4Q
09/30/2022
21.68%
5Q
06/30/2022
22.94%
6Q
03/31/2022
26.86%
7Q
12/31/2021
27.38%
8Q
09/30/2021
27.96%
9Q
06/30/2021
28.39%
10Q
03/31/2021
28.94%
11Q
12/31/2020
34.96%
12Q
09/30/2020
51.41%
13Q
06/30/2020
67.19%
14Q
03/31/2020
71.68%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR REPLIMUNE GROUP INC
LOADING...